CD47 and pancreatic ductal adenocarcinoma: NDV-mediated CD47 blockade did not improve animal survival in B16-F10 melanoma nor KPC pancreatic ductal adenocarcinoma (PDAC), but greater incidence of tumor clearance resulting in immunological memory was observed in PDAC compared to B16-F10 tumor-bearing mice.